Interpersonal Psychotherapy for Depressed Adolescents and Parents
NCT ID: NCT00619411
Last Updated: 2012-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
10 participants
INTERVENTIONAL
2007-11-30
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Parent Involvement in the Treatment of Adolescent Depression
NCT00883519
Psychotherapy for Depressed Mothers of Psychiatrically Ill Children
NCT00919594
Interpersonal Psychotherapy for Depressed Adolescents Engaging in Non-suicidal Self-injury
NCT00401102
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
NCT01447602
Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics
NCT00270244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will receive 15 weeks of Interpersonal Psychotherapy for Depressed Adolescents and Parents (IPT-AP). Eight the therapy sessions are conducted with the adolescent individually, two are with the parent(s) individually, and five are conducted with the adolescent and parent(s) together. At the end of the 15 weeks, participants who have demonstrated at least a 50% reduction in depressive symptoms will participate in three booster sessions delivered on a monthly basis. All participants will be assessed at baseline, week 5, week 10, week 15 (post-treatment), and 3 months post-treatment to measure depressive symptoms, global and social functioning, and attitudes toward treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
I
Interpersonal Therapy for Depressed Adolescents & Parents
15 weekly psychotherapy sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interpersonal Therapy for Depressed Adolescents & Parents
15 weekly psychotherapy sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score between 10 and 28 on the HRSD
* Score of 65 or less on the C-GAS
* English-speaking adolescent
* Parental or legal guardian consent to participate
Exclusion Criteria
* Score greater than 28 on the HRSD
* Mentally retarded
* Meets diagnostic criteria for current substance abuse, schizophrenia, bipolar disorder, psychosis, conduct disorder, or eating disorder
* Currently in active treatment for depression
* Taking antidepressant medication at the time of baseline assessment
* Medical illness likely to complicate or interfere with treatment
* Victim of ongoing or previously undisclosed child abuse
* Parent psychiatrically hospitalized within the past 3 months
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meredith Gunlicks-Stoessel, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5549
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.